FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndGross margin (%) YoY (%)
Mar 31, 202556.6+12.07%
Mar 31, 202450.5+11.75%
Mar 31, 202345.2-11.35%
Mar 31, 202251+10.55%
Mar 31, 202146.1+19.44%
Mar 31, 202038.6-11.87%
Mar 31, 201943.8+2.40%
Mar 31, 201842.8+10.64%
Mar 31, 201738.7-13.22%
Mar 31, 201644.6-10.71%
Mar 31, 201549.9
AI Chat